| Electrolyte and hormonal disorders | Lifetime | 26 | SE 1 | 99.41 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 50 | SE 1 | 99.17 |
| Hormonal Regulation and Hypertension | Lifetime | 137 | SE 2 | 99.22 |
| Blood Pressure and Hypertension Studies | Lifetime | 268 | SE 7 | 99.11 |
| Diet and metabolism studies | Lifetime | 601 | SE 21 | 98.92 |
| Lipoproteins and Cardiovascular Health | Lifetime | 242 | SE 6 | 98.86 |
| Heart Failure Treatment and Management | Lifetime | 327 | SE 14 | 98.78 |
| Heart Rate Variability and Autonomic Control | Lifetime | 515 | SE 8 | 98.31 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 421 | SE 13 | 97.81 |
| Genetic Associations and Epidemiology | Lifetime | 279 | SE 5 | 98.50 |
| Cardiovascular Health and Disease Prevention | Lifetime | 471 | SE 7 | 97.79 |
| Cancer, Lipids, and Metabolism | Lifetime | 705 | SE 16 | 97.53 |
| Ion Transport and Channel Regulation | Lifetime | 280 | SE 3 | 97.19 |
| Nutritional Studies and Diet | Lifetime | 966 | SE 26 | 97.12 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 925 | SE 27 | 96.42 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 945 | SE 27 | 97.09 |
| Sodium Intake and Health | Lifetime | 323 | SE 4 | 95.21 |
| Apelin-related biomedical research | Lifetime | 313 | SE 3 | 92.31 |
| Nutrition, Genetics, and Disease | Lifetime | 811 | SE 15 | 92.22 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 878 | SE 11 | 89.02 |
| GDF15 and Related Biomarkers | Lifetime | 357 | SE 18 | 85.77 |
| Potassium and Related Disorders | Lifetime | 921 | SE 23 | 85.51 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 99 | SE 3 | 96.52 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 243 | SE 4 | 94.14 |
| Diet and metabolism studies | 2021-2025 | 701 | SE 15 | 93.97 |
| Neuropeptides and Animal Physiology | 2021-2025 | 107 | SE 3 | 91.52 |
| Heart Failure Treatment and Management | 2021-2025 | 568 | SE 16 | 93.33 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 978 | SE 13 | 85.11 |
| Electrolyte and hormonal disorders | 2021-2025 | 272 | SE 8 | 81.18 |
| Regulation of Appetite and Obesity | 2021-2025 | 629 | SE 18 | 72.77 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 631 | SE 14 | 71.92 |
| GDF15 and Related Biomarkers | 2021-2025 | 275 | SE 16 | 69.53 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 621 | SE 13 | 73.27 |
| Nutrition, Genetics, and Disease | 2021-2025 | 967 | SE 14 | 67.00 |
| Apelin-related biomedical research | 2021-2025 | 308 | SE 1 | 60.39 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 329 | SE 1 | 58.59 |
